Advances in gene editing and cell therapies have recently led to outstanding clinical successes. However, the lack of a cost-effective manufacturing process prevents the democratization of these innovative medical tools. Due to the common use of viral vectors, the step of transfection in which cells are engineered to gain new functions, is a major bottleneck in making safe and affordable cell products.
Quality by Design NV
Fotografielaan 5
2610 Wilrijk
Belgium
T:+32 3 844 45 01
VAT: BE 838 540 254